Speech-Language Pathologists in Bartonville, IL Accepting Medicare
4 Speech-Language Pathologists found. Showing 1 - 4
 Sara Rearden Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4812 W. Pfeiffer Road, Bartonville, IL 61607 Phone: 309-697-0880 |
Megan Livermore Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4812 Pfeiffer Rd, Bartonville, IL 61607 Phone: 309-697-0880 |
Allison Clare Norris, M.S, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4812 Pfeiffer Rd, Bartonville, IL 61607 Phone: 815-351-9522 |
Lesley Shanks, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4812 Pfeiffer Rd, Bartonville, IL 61607 Phone: 309-697-0880 |
News Archive
FDA grants clearance to new blood cell count test that allows faster availability of results
The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians' offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.
ESCMID gathers more solid data to better assess Zika virus risks, prepares for possible outbreak in Africa, Europe
Experts at the European Society of Clinical Microbiology and Infectious Diseases – an organization promoting research, risk assessment, knowledge sharing and best practices in the fight against infectious diseases – are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
Proteomics completes important milestone towards development of CDx test with validation of protein biomarkers
Proteomics now seeks a commercialisation partner to enter the RUO, LDT or IVD markets. Drug discovery company Proteomics International has completed an important milestone towards the development of a companion diagnostic (CDx) test with the validation of several of its protein biomarkers.
Anti-inflammatory therapy helps slow progression of multiple sclerosis in a preclinical model
Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research out of the University of Alberta.
› Verified 6 days ago